AstraZeneca Pharma India Limited

AstraZeneca Pharma India Limitedverified

ASTRAZEN.BO

Price:

$9211.5

Market Cap:

$230.66B

AstraZeneca Pharma India Limited, a biopharmaceutical company, engages in manufacturing, distributing, and marketing of pharmaceutical products in India and internationally. It manufactures and sells cardiovascular disease and diabetes medicines under the Brilinta, Betaloc, Crestor, Forxiga, Imdur, Kombiglyze XR, Onglyza, Seloken XL, Xigduo XR, and QTERN brand names; Respiratory medicines under the Symbicort and FASENRA brand names; and oncology medicines under the LYNPARZA, Tagrisso, Iressa, Calquence, Casodex, Faslodex, Zoladex, and Arimidex brand names. The company also offers products in the areas of renal, metabolic, and immunology diseases. It also provides clinical trial services. The...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2000-07-10

Stock Exchange

BSE

Ticker

ASTRAZEN.BO

The PE Ratio as of December 2025 (TTM) for AstraZeneca Pharma India Limited (ASTRAZEN.BO) is 116.28

According to AstraZeneca Pharma India Limited’s latest financial reports and current stock price. The company's current PE Ratio is 116.28. This represents a change of 4.80% compared to the average of 110.95 of the last 4 quarters.

AstraZeneca Pharma India Limited (ASTRAZEN.BO) Historical PE Ratio (quarterly & annually)

How has ASTRAZEN.BO PE Ratio performed in the past?

The mean historical PE Ratio of AstraZeneca Pharma India Limited over the last ten years is 146.18. The current 116.28 PE Ratio has changed 7.85% with respect to the historical average. Over the past ten years (40 quarters), ASTRAZEN.BO's PE Ratio was at its highest in in the March 2016 quarter at 1.29K. The PE Ratio was at its lowest in in the June 2024 quarter at -338.63.

Quarterly (TTM)
Annual

Average

146.18

Median

91.48

Minimum

80.50

Maximum

548.94

AstraZeneca Pharma India Limited (ASTRAZEN.BO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of AstraZeneca Pharma India Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 127.86%

Maximum Annual PE Ratio = 548.94

Minimum Annual Increase = -596.90%

Minimum Annual PE Ratio = 80.50

Quarterly (TTM)
Annual
YearPE RatioChange
2025183.43127.86%
202480.50-1.71%
202381.90-20.92%
2022103.5728.44%
202180.64-3.11%
202083.22-9.86%
201992.331.87%
201890.64-22.28%
2017116.61-78.76%
2016548.94-596.90%

AstraZeneca Pharma India Limited (ASTRAZEN.BO) Average PE Ratio

How has ASTRAZEN.BO PE Ratio performed in the past?

The current PE Ratio of AstraZeneca Pharma India Limited (ASTRAZEN.BO) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

115.28

5-year avg

106.01

10-year avg

146.18

AstraZeneca Pharma India Limited (ASTRAZEN.BO) PE Ratio vs. Peers

How is ASTRAZEN.BO’s PE Ratio compared to its peers?

AstraZeneca Pharma India Limited’s PE Ratio is greater than Neuland Laboratories Limited (90.22), greater than Neuland Laboratories Limited (90.22), greater than Piramal Enterprises Limited (43.81), greater than Piramal Pharma Limited (-1000.74), greater than J. B. Chemicals & Pharmaceuticals Limited (39.73), greater than J. B. Chemicals & Pharmaceuticals Limited (39.73), greater than Eris Lifesciences Limited (50.87), greater than Eris Lifesciences Limited (50.87), greater than Wockhardt Limited (-960.82), greater than Wockhardt Limited (-960.82),

Build a custom stock screener for AstraZeneca Pharma India Limited (ASTRAZEN.BO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AstraZeneca Pharma India Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AstraZeneca Pharma India Limited (ASTRAZEN.BO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AstraZeneca Pharma India Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is AstraZeneca Pharma India Limited's PE Ratio?

How is the PE Ratio calculated for AstraZeneca Pharma India Limited (ASTRAZEN.BO)?

What is the highest PE Ratio for AstraZeneca Pharma India Limited (ASTRAZEN.BO)?

What is the 3-year average PE Ratio for AstraZeneca Pharma India Limited (ASTRAZEN.BO)?

What is the 5-year average PE Ratio for AstraZeneca Pharma India Limited (ASTRAZEN.BO)?

How does the current PE Ratio for AstraZeneca Pharma India Limited (ASTRAZEN.BO) compare to its historical average?